Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Net revenue:
Rental	$ 2,480	$ 2,191
Product and supply	7,989	7,381
Pharmacy and other	1,172	1,545
Net revenue	11,641	11,117
Operating Expenses
Cost of revenue – rental, product and supply	(4,937)	(4,957)
Cost of revenue – noncore inventory write-off		(2,655)
Selling, general and administrative expenses	(9,185)	(11,397)
Net gain on lease termination		2,195
Loss from operations	(2,481)	(5,697)
Other income (expense):
Interest expense	(503)	(536)
Other income (expense)	(7)	(47)
Total other income (expense)	(510)	(583)
Loss before income taxes	(2,991)	(6,280)
Income tax benefit	57	49
Net loss	(2,934)	(6,231)
Plus: Net loss – non-controlling interest	23	32
Net loss – attributable to Zynex, Inc.	$ (2,911)	$ (6,199)
Net loss per share – attributable to Zynex, Inc.:
Basic	$ (0.09)	$ (0.20)
Diluted	$ (0.09)	$ (0.20)
Weighted average number of common shares outstanding:
Basic	31,271,234	31,207,672
Diluted	31,271,234	31,207,672